U.S. markets open in 1 hour 26 minutes

Bausch Health Companies Inc. (BHC)

NYSE - Nasdaq Precio en tiempo real. Moneda en USD.
Añadir a la lista de seguimiento
7.60+0.22 (+2.98%)
Al cierre: 04:00PM EDT
7.63 +0.03 (+0.40%)
Antes de la apertura del mercado: 07:45AM EDT

Bausch Health Companies Inc.

2150 St. ElzEar Boulevard West
Laval, QC H7L 4A8
Canada
514 744 6792
https://www.bauschhealth.com

Sector(es)Healthcare
IndustriaDrug Manufacturers - Specialty & Generic
Empleados a tiempo completo20,270

Ejecutivos clave

NombreTítuloPagarEjecutadoAño de nacimiento
Mr. Thomas J. AppioCEO & Director2.74MN/D1962
Mr. John S. BarresiSenior VP, Controller, Chief Accounting Officer & Interim CFO796.8kN/D1973
Ms. Seana CarsonExecutive VP & General Counsel872.65kN/D1973
Mr. Mirza DautbegovicExecutive VP & COON/DN/DN/D
Ms. Kathleen FitzpatrickExecutive VP and Chief HR & Communications OfficerN/DN/DN/D
Mr. Josh CoyleSenior Vice President of Sales & SalixN/DN/DN/D
Dr. Tage Ramakrishna M.D.Chief Medical Officer and President of R&DN/DN/D1974
Mr. Jeff HartnessExecutive VP of Market Access, Commercial Operations, Neurology, Generics & Government AffairsN/DN/DN/D
Dr. Graham JacksonSenior VP & Chief Quality OfficerN/DN/DN/D
Mr. Cees HeimanSenior Vice President of Europe & CanadaN/DN/DN/D
Los importes son a partir de 31 de diciembre de 2023 y los valores de compensación son para el último año fiscal que finaliza en esa fecha. Pago corresponde al salario, las bonificaciones, etc. Ejecutado corresponde al valor de las opciones ejecutadas durante el año fiscal. Divisa en USD.

Descripción

Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health. The company operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The Salix segment provides gastroenterology products in the United States. The International segment sells aesthetic medical devices, branded pharmaceuticals, generic pharmaceuticals, and OTC products internationally. The Solta Medical segment engages in the sale of aesthetic medical devices. The Diversified segment offers pharmaceutical products in the areas of neurology and certain other therapeutic classes; generic products; ortho dermatologic; and dentistry products in the United States. The Bausch + Lomb segment offers products in the areas of vision care, surgical, and ophthalmic pharmaceuticals products. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.

Gestión corporativa

La calificación ISS Governance QuickScore de Bausch Health Companies Inc. a partir del 1 de julio de 2024 es 3. Las puntuaciones principales son Auditoría: 7; Junta: 2; Derechos del accionista: 3; Compensación: 5.

Las puntuaciones de la gestión corporativa son cortesía de Servicios de accionistas institucionales (ISS). Las puntuaciones indican una posición decil en relación con el índice o la región. Una puntuación decil 1 indica que el riesgo de gestión es menor, mientras que una puntuación decil 10 indica que el riesgo de gestión es mayor.